The amount and localization of ZO-1 and Ocln are dynamically altered and affect rate and degree of tight junction degradation and reformation, processes critical to diseases of barrier dysfunction at the interface between blood and brain, liver, kidney, and tumor (among others). This evidence concerns the gene TJP1 and neoplasm.